通过微环境响应性氧化释放水凝促进血管生成的光声学成像
Yuxuan Hai1,2, Haiyang Xia3, Chengtian Hou1,2
1Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Institute of Photonics Technology, Jinan University, Guangzhou 510632, China.
ACS applied materials & interfaces
|November 21, 2025
概括
这项研究引入了一种新型的凝伤口合剂,可释放氧化,并使用光学分辨率光声显微镜 (OR-PAM) 进行监测. 这种神经治疗平台能够精确地在体内跟踪伤口愈合和新血管化,以改善慢性伤口治疗.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 医疗成像医学成像
背景情况:
- 含有药物的水凝可以为伤口愈合提供受控释放,但缺乏体内监测方法.
- 活体组织学限制了对新血管化和治疗疗效的纵向评估.
- 开发超神论平台对于精确的慢性伤口管理至关重要.
研究的目的:
- 开发和评估一种对氧化还原反应敏感的水凝敷料,用于持续释放氧化.
- 使用光学分辨率光声学显微镜 (OR-PAM) 进行伤口新血管化的纵向体内成像.
- 为准确评估在慢性伤口治疗中水凝敷料的疗效建立一个神经治疗平台.
主要方法:
- 通过酸乙烯介导的酸四化,为持续的氧化 (NO) 释放设计了一种瓜诺辛酸盐水凝.
- 用S-nitrosoglutathione加载的水凝给小鼠耳朵的伤口.
- 采用光学分辨率光声显微镜 (OR-PAM) 进行两周的纵向微血管成像.
主要成果:
- 水凝显示了持续的NO释放超过100小时.
- OR-PAM揭示了动态的微血管改造,包括发芽和分支.
- 与对照组相比,经过治疗的伤口显示血管区域密度 (63%) 和血管总长度 (49%) 显著增加.
结论:
- 开发的水凝敷料表现出卓越的生物相容性和持续的药物释放,促进新血管化.
- OR-PAM提供高分辨率的纵向成像,以准确评估伤口愈合.
- 集成的水凝-OR-PAM系统为慢性伤口治疗,包括糖尿病,提供了一个有前途的治疗方法.
更多相关视频
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
10.1K
10:47Standardized and Scalable Assay to Study Perfused 3D Angiogenic Sprouting of iPSC-derived Endothelial Cells In Vitro
Published on: November 6, 2019
31.1K
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
